JP2001524814A - 28種類のヒト分泌タンパク質 - Google Patents

28種類のヒト分泌タンパク質

Info

Publication number
JP2001524814A
JP2001524814A JP53980098A JP53980098A JP2001524814A JP 2001524814 A JP2001524814 A JP 2001524814A JP 53980098 A JP53980098 A JP 53980098A JP 53980098 A JP53980098 A JP 53980098A JP 2001524814 A JP2001524814 A JP 2001524814A
Authority
JP
Japan
Prior art keywords
polypeptide
sequence
polynucleotide
seq
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP53980098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001524814A5 (cg-RX-API-DMAC10.html
Inventor
ルーベン,スティーブン・エム
ローゼン,クレイグ・エイ
リ,イ
ツェン,ツィーツェン
キャウ,フラ
フィッシャー,キャリー・エル
リ,ハオドン
ソペット,ダニエル・アール
ジェンツ,ライナー・エル
ウェイ,イン・フェイ
ムーア,ポール・エイ
ヤング,ポール・イー
グリーン,ジョン・エム
フェリー,アン・エム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JP2001524814A publication Critical patent/JP2001524814A/ja
Publication of JP2001524814A5 publication Critical patent/JP2001524814A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP53980098A 1997-03-14 1998-03-12 28種類のヒト分泌タンパク質 Withdrawn JP2001524814A (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US4071097P 1997-03-14 1997-03-14
US4076297P 1997-03-14 1997-03-14
US5093497P 1997-05-30 1997-05-30
US4835797P 1997-05-30 1997-05-30
US4818997P 1997-05-30 1997-05-30
US4810097P 1997-05-30 1997-05-30
US4897097P 1997-06-06 1997-06-06
US5776597P 1997-09-05 1997-09-05
US6836897P 1997-12-19 1997-12-19
US60/040,710 1997-12-19
US60/057,765 1997-12-19
US60/050,934 1997-12-19
US60/048,189 1997-12-19
US60/048,100 1997-12-19
US60/048,357 1997-12-19
US60/068,368 1997-12-19
US60/040,762 1997-12-19
US60/048,970 1997-12-19
PCT/US1998/004858 WO1998040483A2 (en) 1997-03-14 1998-03-12 28 human secreted proteins

Publications (2)

Publication Number Publication Date
JP2001524814A true JP2001524814A (ja) 2001-12-04
JP2001524814A5 JP2001524814A5 (cg-RX-API-DMAC10.html) 2005-11-10

Family

ID=27578155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53980098A Withdrawn JP2001524814A (ja) 1997-03-14 1998-03-12 28種類のヒト分泌タンパク質

Country Status (6)

Country Link
US (1) US6448230B1 (cg-RX-API-DMAC10.html)
EP (1) EP0973892A2 (cg-RX-API-DMAC10.html)
JP (1) JP2001524814A (cg-RX-API-DMAC10.html)
AU (1) AU6552198A (cg-RX-API-DMAC10.html)
CA (1) CA2283678A1 (cg-RX-API-DMAC10.html)
WO (1) WO1998040483A2 (cg-RX-API-DMAC10.html)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015797A2 (en) * 1998-09-17 2000-03-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO1999014241A2 (en) * 1997-09-17 1999-03-25 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6919433B2 (en) 1997-03-14 2005-07-19 Human Genome Sciences, Inc. Antibodies to protein HPMBQ91
US6951924B2 (en) * 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
EP0973892A2 (en) 1997-03-14 2000-01-26 Human Genome Sciences, Inc. 28 human secreted proteins
EP0892053A3 (en) * 1997-07-14 1999-12-29 Smithkline Beecham Plc production of recombinant HPMBQ91 polypeptide and uses thereof
JP2001516009A (ja) * 1997-07-17 2001-09-25 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ ガン関連核酸及びポリペプチド
US6410708B1 (en) * 1997-11-21 2002-06-25 Genentech, Inc. Nucleic acids encoding A-33 related antigen polypeptides
EP1025223A2 (en) * 1997-09-19 2000-08-09 Magainin Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US20030054463A1 (en) * 1997-10-24 2003-03-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US7282565B2 (en) 1998-03-20 2007-10-16 Genentech, Inc. PRO362 polypeptides
US7198917B2 (en) 1997-11-21 2007-04-03 Genentech, Inc. Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
DK1481990T3 (da) * 1997-11-21 2007-10-01 Genentech Inc A33-beslægtede antigener og deres farmakologiske anvendelser
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US6686147B1 (en) 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
EP1124840A4 (en) * 1998-10-28 2002-07-17 Baylor College Medicine GENES AND PROTEINS SPECIFIC TO OVARIES
US7335737B2 (en) 1998-10-28 2008-02-26 Baylor College Of Medicine Ovary-specific genes and proteins
US6995251B1 (en) 1999-10-28 2006-02-07 Baylor Ovary-specific genes and proteins
DK1141331T3 (da) 1998-12-16 2009-01-05 Novartis Vaccines & Diagnostic Human cyclinafhængig kinase (hPNQALRE)
AU777909B2 (en) 1999-01-19 2004-11-04 Lexicon Genetics Incorporated Mammalian cortexin-like proteins and polynucleotides encoding the same
AU2757500A (en) * 1999-02-10 2000-08-29 Human Genome Sciences, Inc. 33 human secreted proteins
MXPA01009110A (es) * 1999-03-11 2002-08-20 Rmf Dictagene Sa Moleculas de adhesion vascular y modulacion de su funcion.
JP2002538810A (ja) * 1999-03-12 2002-11-19 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 50個のヒト分泌タンパク質
CA2368068A1 (en) * 1999-03-18 2000-09-21 Steven M. Ruben 27 human secreted proteins
EP1171626A4 (en) * 1999-03-26 2002-10-30 Human Genome Sciences Inc 50 HUMANE SECRETIED PROTEINS
JP2002539816A (ja) * 1999-03-26 2002-11-26 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 50個のヒト分泌タンパク質
JP2003500014A (ja) * 1999-03-26 2003-01-07 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 50個のヒト分泌タンパク質
EP1177214A4 (en) * 1999-04-09 2003-01-02 Human Genome Sciences Inc 49 HUMAN SECRETIED GENES
CA2383828A1 (en) * 1999-06-07 2000-12-14 Human Genome Sciences, Inc. 26 human secreted proteins
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1514933A1 (en) * 1999-07-08 2005-03-16 Research Association for Biotechnology Secretory protein or membrane protein
AU6906800A (en) * 1999-08-17 2001-03-13 Incyte Genomics, Inc. Membrane associated proteins
WO2001031004A1 (fr) * 1999-10-27 2001-05-03 Takeda Chemical Industries, Ltd. Nouvelle proteine et son utilisation
AU1174501A (en) * 1999-11-10 2001-06-06 Compugen Ltd. Chordin-like homologs
US7018810B1 (en) * 1999-12-07 2006-03-28 Amgen Inc. Chordin-like molecules and uses thereof
US20030068624A1 (en) * 2000-10-26 2003-04-10 Recipon Herve E. Compositions and methods relating to lung specific genes and proteins
US20050123990A1 (en) * 2001-09-26 2005-06-09 Incyte Corporation Membrane associated proteins
JP4360915B2 (ja) 2002-01-07 2009-11-11 ユーロスクリーン・ソシエテ・アノニム Gタンパク質共役受容体gpr43のリガンドおよびその使用
WO2003102136A2 (en) 2002-05-30 2003-12-11 Human Genome Sciences, Inc. Antibodies that specifically bind to neurokinin b
US7056685B1 (en) * 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
HRP20161580T1 (hr) 2008-05-06 2016-12-30 Genentech, Inc. CRIg-VARIJANTE S RAZVIJENIM AFINITETOM

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
EP0679716A4 (en) * 1993-11-12 1999-06-09 Kenichi Matsubara GENE SIGNATURE.
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
EP0973892A2 (en) 1997-03-14 2000-01-26 Human Genome Sciences, Inc. 28 human secreted proteins
CA2338386A1 (en) 1998-08-10 2000-02-24 Incyte Pharmaceuticals, Inc. Proteases and associated proteins

Also Published As

Publication number Publication date
WO1998040483A2 (en) 1998-09-17
US6448230B1 (en) 2002-09-10
CA2283678A1 (en) 1998-09-17
EP0973892A2 (en) 2000-01-26
AU6552198A (en) 1998-09-29
WO1998040483A3 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
US7169565B2 (en) Antibodies to HASAV70 polypeptide
JP2002513295A (ja) 123種類のヒト分泌タンパク質
US20090088555A1 (en) 44 Human Secreted Proteins
US20070248593A1 (en) 32 Human Secreted Proteins
US7906634B2 (en) HEMCM42 nucleic acids
JP2002518010A (ja) 94個のヒト分泌タンパク質
JP2002533058A (ja) 97個のヒト分泌タンパク質
JP2002508167A (ja) 110個のヒト分泌タンパク質
JP2009131263A (ja) 50個のヒト分泌タンパク質
CA2283678A1 (en) 28 human secreted proteins
JP2001521383A (ja) 20個のヒト分泌タンパク質
JP2002501738A (ja) 67個のヒト分泌タンパク質
JP2002500035A (ja) 36個のヒト分泌タンパク質
JP2001514885A (ja) 70個のヒト分泌タンパク質
JP2003525566A (ja) 125個のヒト分泌タンパク質
JP2003524366A (ja) 64個のヒト分泌タンパク質
JP2002514925A (ja) 19個のヒト分泌タンパク質
JP2001519179A (ja) 53個のヒト分泌タンパク質
JP2003521216A (ja) 90個のヒト分泌タンパク質
JP2003521865A (ja) 148個のヒト分泌タンパク質
US20010016647A1 (en) 29 human secreted proteins
JP2003521215A (ja) 83個のヒト分泌タンパク質
US20050069943A1 (en) 101 human secreted proteins
JP2002504361A (ja) 36個のヒト分泌タンパク質
JP2002514090A (ja) 86種類のヒト分泌タンパク質

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050301

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20060307